On the Possibilities of Combining Budget Impact Analysis and Cost-Effectiveness Analysis - Development of «3D» Pharmacoeconomic Model

Pharmacoeconomics: theory and practice
doi 10.30809/phe.3.2014.8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Moscow Pharmaceutical Society

Related search

Pcv46 - Pharmacoeconomic Evaluation and Budget Impact Analysis of Ivabradine in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Uptake of Non-Vitamin K Oral Anticoagulants in Ireland: Balancing Cost-Effectiveness Analysis and Budget Impact

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Cost-Effectiveness and Budget Impact of the Community-Based Management of Hypertension in Nepal Study (COBIN): A Retrospective Analysis

The Lancet Global Health
Medicine
2019English

Combining Multiple Imputation and Bootstrap in the Analysis of Cost-Effectiveness Trial Data

Statistics in Medicine
EpidemiologyStatisticsProbability
2018English

The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

Pcn90 - Cost-Effectiveness and Budget Impact Analysis of Nilotinib for the Second Line Tratment of Chronic Mieloid Leukemia in the Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis

Dental Abstracts
2012English

The Limits of Cost-Effectiveness Analysis

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2009English

Cost-Effectiveness Analysis.

BMJ
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy